Working… Menu

Bioequivalence Study of Montelukast, 5 mg Chewable Tablets (Pharmtechnology LLC, Belarus), and Singulair®, 5 mg Chewable Tablets (Merck Sharp & Dohme B.V., the Netherlands), in Healthy Volunteers Under Fasting Conditions

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03898193
Recruitment Status : Completed
First Posted : April 1, 2019
Last Update Posted : June 6, 2019
ClinPharmInvest, LLC
Information provided by (Responsible Party):
Pharmtechnology LLC

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 8, 2019
Actual Study Completion Date : April 8, 2019